Investing

ON Semiconductor Presents a Rare Contrarian Setup ON Semiconductor (ON) is navigating a complex transition. The company is integrating a $7 billion all-stock acquisition of Synaptics (SYNA), an edge-AI and connectivity chipmaker. While execution risk has spooked investors — creating severe negative order flow — the strategic move positions ON deeper into the competitive AI … Read more

Carillon Tower Advisers Highlights Vertiv as Prime AI Infrastructure Beneficiary Carillon Tower Advisers, a prominent investment management firm, has identified Vertiv Holdings Co (NYSE: VRT) as a standout beneficiary of accelerating artificial intelligence infrastructure spending in its second-quarter 2026 investor letter for the Carillon Eagle Mid Cap Growth Fund. The firm’s analysis comes amid a … Read more

AMD’s Pre-Earnings Dip Offers Attractive Entry Point for Long-Term Investors Advanced Micro Devices (AMD) shares have retreated more than 22% from recent highs as the semiconductor giant approaches its second-quarter earnings report scheduled for Tuesday, August 4. This pullback, driven by profit-taking after a strong rally and broader weakness in AI-related equities, may represent a … Read more

The Tale of Two Pharma Giants In the pharmaceutical sector, few rivalries capture the investment dichotomy better than Pfizer (NYSE: PFE) and Eli Lilly (NYSE: LLY). With a combined market capitalization exceeding $300 billion, these titans represent opposing investment philosophies: Pfizer as a deep-value, high-yield income play, and Eli Lilly as a premium-priced growth compounder … Read more

Southwest Airlines Stages Impressive Comeback Amid Fuel Cost Headwinds Valued at a market cap of $18.6 billion, Southwest Airlines Co. (NYSE: LUV) remains one of the largest domestic carriers in the United States, serving over 100 destinations across the U.S., Mexico, the Caribbean, and Central America. Headquartered in Dallas, Texas, the airline is renowned for … Read more

Apple Shares Plunge on Disappointing Revenue Outlook Apple Inc. (AAPL) shares sank approximately 7% on Friday, erasing billions in market capitalization after the Cupertino giant delivered a fiscal third-quarter report that, while beating earnings estimates, issued a revenue forecast that fell sharply below Wall Street expectations. The selloff highlights growing investor anxiety over the company’s … Read more

Datadog, Inc. (NASDAQ: DDOG) shares climbed 7.7% on July 28, 2026, after three major Wall Street firms—Morgan Stanley, BTIG, and Citi—raised their price targets to $300, $289, and $300 respectively. The upward revisions, ranging from 11% to 33%, reflect growing confidence in the observability platform’s ability to monetize the artificial intelligence infrastructure boom. However, the … Read more

Indivior Pharmaceuticals Shows Strength Amid Opioid Crisis Shares of Indivior Pharmaceuticals (INDV) are attempting to carve out a fresh buy point after the company reported a staggering 108% surge in profits, underscoring the growing demand for its opioid addiction treatments. The Virginia-based biopharmaceutical firm, a pure-play specialist in Opioid Use Disorder (OUD), has seen its … Read more

Cencora Demonstrates Resilience Amid Temporary Headwinds Carillon Tower Advisers, through its Carillon Eagle Mid Cap Growth Fund, recently highlighted Cencora Inc. (NYSE: COR) in its second-quarter 2026 investor letter as a compelling investment despite near-term challenges. The pharmaceutical sourcing and distribution giant closed at $311.15 on July 30, 2026, delivering a 4.74% one-month return and … Read more